Search results
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 5 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 6 days ago“With five vaccine programmes that have achieved positive Phase III results, Moderna's platform is...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters via Yahoo News· 7 days agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 2 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-...
The Joplin Globe· 7 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy
Moderna’s next-gen COVID vaccine shows non-inferiority to its current shot
WSAU Wausau· 7 days ago(Reuters) -Moderna said on Thursday its next-generation COVID-19 vaccine candidate met its main goal...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 7 days agosaid Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed...
Kansas sues Pfizer over ‘misleading statements’ about COVID vaccine
The Hill via Yahoo News· 2 days agoThe state of Kansas filed a lawsuit Monday against pharmaceutical company Pfizer, alleging the...
Moderna Just Gave Investors Another Reason to Buy the Stock
The Motley Fool via AOL· 4 days agoHowever, the biotech has been looking to...it announced positive clinical news that should have...
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 7 days agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...